Demarest and R. Amaral Advogados advised on the deal Hemoterapia Brasil S.A. executed the acquisition of 100 % stake in Fujisan and Hematología del Ceará. Contestually…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
